Axecap Investments, LLC Abb Vie Inc. Transaction History
Axecap Investments, LLC
- $132 Billion
- Q3 2024
A detailed history of Axecap Investments, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Axecap Investments, LLC holds 21,834 shares of ABBV stock, worth $4.14 Million. This represents 3.27% of its overall portfolio holdings.
Number of Shares
21,834Holding current value
$4.14 Million% of portfolio
3.27%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
3,757Shares Held
1.28BCall Options Held
13MPut Options Held
9.84M-
Vanguard Group Inc Valley Forge, PA171MShares$32.3 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$14.7 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.1 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.31 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $335B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...